PT Surya Biru Murni Acetylene Tbk EBIT

The latest EBIT for SBMA.JK is $14B as of June 2026. That compares with $22B in the prior-year period — down 37.4% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside PT Surya Biru Murni Acetylene Tbk's historical trend and sector peers before judging valuation or financial health.

Over the past year, SBMA.JK's EBIT moved from $22B to $14B — a 37.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Surya Biru Murni Acetylene Tbk's operating scale or balance-sheet position.

Against its sector companies, SBMA.JK currently prints $14B for EBIT, while the sector average sits near $2.5T. That is roughly 99.5% below the sector mean. Large gaps often invite a closer look at PT Surya Biru Murni Acetylene Tbk's growth, margins, and balance sheet.

A EBIT figure of $14B for SBMA.JK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting SBMA.JK's EBIT ($14B), review year-over-year change from $22B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.